Progress of Resistant Starch Diet Therapy in Treatment of Inflammatory Bowel Disease
10.3969/j.issn.1008-7125.2022.03.009
- Author:
Shu YUAN
1
;
Kang DING
2
;
Yanyan TAN
2
Author Information
1. Nanjing University of Chinese Medicine
2. Department of Proctology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Inflammatory Bowel Disease;
Resistant Starch;
Short-Chain Fatty Acids;
Therapy
- From:
Chinese Journal of Gastroenterology
2022;27(3):182-186
- CountryChina
- Language:Chinese
-
Abstract:
As a disease that requires long-term treatment, the safety of treatment is particularly important in the treatment of inflammatory bowel disease (IBD). Numerous studies have shown that diet can alter the intestinal barrier, IBD susceptibility gene expression, immune function, and microbial metabolites by influencing the balance of gut microbes. Diet is therefore one of the key environmental factors that affect the symptoms and recurrence of IBD. The resistant starch diet can increase the viscosity of feces, promote the proliferation of colon symbiotic bacteria and generate a large number of short-chain fatty acids, which is highly correlated with the course of IBD. This article reviewed the progress of resistant starch in treatment of IBD.
